Chris Keith is Solco Healthcare’s Senior Vice President of Marketing and Business Development. Chris utilizes his more than 25 years of sales, marketing and business development experience in helping Solco achieve its market share and profitability goals. He continues to be part of the senior management team at Prinston Pharmaceutical with the responsibility of identifying strategic opportunities for the company.
Prior to joining Solco, Chris worked at Prinston Pharmaceutical as Vice President, Marketing and Business Development where he successfully negotiated and closed multiple generic drug development deals and several in-licensing, as well as out-licensing opportunities for Prinston. Prior to Prinston, Chris co-founded Éclat Pharmaceuticals where he served as the company’s Executive Vice President, Sales and Marketing. During his time at Éclat, Chris focused on identifying and commercializing niche brand and generic products including several 505(b)(2) injectables and various liquid narcotic products.
Before Éclat, Chris spent 18 years with ETHEX Corporation. During his time at ETHEX, Chris held various roles but spent the majority of his time leading the marketing team as the Vice President, Marketing. Chris was responsible for directing the overall planning, design and implementation of all marketing, advertising and promotional activities relating to both current and future generic pharmaceutical products. Chris and his team were responsible for launching over 50 products with 87% of ETHEX’s products ranked #1 or #2 in market share position, while increasing net revenues $185.2 million within the last four years of his tenure.
Chris holds a Bachelors of Science in Marketing and Management, as well as a Masters of Business Administration from the University of Missouri St. Louis.